Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes: The randomized multicenter South Danish Diabetes Study

OBJECTIVE: To determine the effect of treatment with insulin aspart compared with NPH insulin, together with metformin/placebo and rosiglitazone/placebo. The hypothesis was that combined correction of major pathogenetic defects in type 2 diabetes would result in optimal glycemic control. RESEARCH DE...

Descripción completa

Detalles Bibliográficos
Autores principales: Gram, Jeppe, Henriksen, Jan Erik, Grodum, Ellen, Juhl, Henning, Hansen, Tony Bill, Christiansen, Christian, Yderstræde, Knud, Gjessing, Hans, Hansen, Henrik M., Vestergaard, Vibe, Hangaard, Jørgen, Beck-Nielsen, Henning
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005476/
https://www.ncbi.nlm.nih.gov/pubmed/20929990
http://dx.doi.org/10.2337/dc10-0531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005476/
https://www.ncbi.nlm.nih.gov/pubmed/20929990
http://dx.doi.org/10.2337/dc10-0531

Ejemplares similares